NEUROPATHIX, INC.: 10-Q filed 2020-11-12

Name: NEUROPATHIX, INC.: 10-Q filed 2020-11-12
Creator: NEUROPATHIX, INC.

What NEUROPATHIX, INC. reported in its quarterly report filed 2020-11-12 (fiscal Q3 2020): 34 published measures, 104 facts as tagged in accession 0001607062-20-000324.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-11-12
Fiscal period: fiscal Q3 2020
Accession: 0001607062-20-000324 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEUROPATHIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-09-30	345,270	USD
At 2019-12-31	223,377	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-09-30	3,081,589	USD
At 2019-12-31	1,917,431	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-09-30	-2,736,319	USD
At 2020-06-30	-2,865,569	USD
At 2019-12-31	-1,694,054	USD
At 2019-09-30	-962,601	USD
At 2019-06-30	-296,944	USD
At 2018-12-31	1,330,933	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-09-30	14,450	USD
At 2019-12-31	121,455	USD
At 2019-09-30	120,550	USD
At 2018-12-31	307,131	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-610,806	USD	92
2020-01-01 to 2020-09-30	-2,977,590	USD	274
2019-07-01 to 2019-09-30	-1,086,497	USD	92
2019-01-01 to 2019-09-30	-2,719,412	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-807,789	USD	274
2019-01-01 to 2019-09-30	-2,000,012	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	0	USD	274
2019-01-01 to 2019-09-30	41,950	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	0	USD	92
2020-01-01 to 2020-09-30	0	USD	274
2019-07-01 to 2019-09-30	23,968	USD	92
2019-01-01 to 2019-09-30	126,027	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	700,784	USD	274
2019-01-01 to 2019-09-30	97	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	0	USD	274
2019-01-01 to 2019-09-30	1,813,334	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-09-30	-11,473,678	USD
At 2019-12-31	-8,496,088	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	74,258,962	shares	92
2020-01-01 to 2020-09-30	74,241,419	shares	274
2019-07-01 to 2019-09-30	70,934,271	shares	92
2019-01-01 to 2019-09-30	70,218,141	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	74,258,962	shares	92
2020-01-01 to 2020-09-30	74,241,419	shares	274
2019-07-01 to 2019-09-30	70,934,271	shares	92
2019-01-01 to 2019-09-30	70,218,141	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-0.01	USD/shares	92
2020-01-01 to 2020-09-30	-0.04	USD/shares	274
2019-07-01 to 2019-09-30	-0.02	USD/shares	92
2019-01-01 to 2019-09-30	-0.04	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-0.01	USD/shares	92
2020-01-01 to 2020-09-30	-0.04	USD/shares	274
2019-07-01 to 2019-09-30	-0.02	USD/shares	92
2019-01-01 to 2019-09-30	-0.04	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274
2019-07-01 to 2019-09-30	USD	92
2019-01-01 to 2019-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-09-30	63,299	USD
At 2019-12-31	75,401	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	1,488,615	USD	274
2019-01-01 to 2019-09-30	275,878	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-805,669	USD	92
2020-01-01 to 2020-09-30	-2,679,475	USD	274
2019-07-01 to 2019-09-30	-767,042	USD	92
2019-01-01 to 2019-09-30	-1,824,987	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-09-30	264,850	USD
At 2019-12-31	130,855	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	151,845	USD	92
2020-01-01 to 2020-09-30	766,212	USD	274
2019-07-01 to 2019-09-30	17,794	USD	92
2019-01-01 to 2019-09-30	49,754	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-09-30	2,092,146	USD
At 2019-12-31	1,327,377	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	805,669	USD	92
2020-01-01 to 2020-09-30	2,679,475	USD	274
2019-07-01 to 2019-09-30	791,010	USD	92
2019-01-01 to 2019-09-30	1,951,014	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	68,546	USD	92
2020-01-01 to 2020-09-30	375,938	USD	274
2019-07-01 to 2019-09-30	189,443	USD	92
2019-01-01 to 2019-09-30	439,680	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-09-30	74,797,037	shares
At 2019-12-31	74,225,141	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-09-30	8,729,879	USD
At 2019-12-31	6,794,612	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2020-09-30	351,797	USD
At 2019-12-31	243,208	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-610,806	USD	92
2020-01-01 to 2020-09-30	-2,977,590	USD	274
2019-07-01 to 2019-09-30	-1,086,497	USD	92
2019-01-01 to 2019-09-30	-2,719,412	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-610,806	USD	92
2020-01-01 to 2020-09-30	-2,977,590	USD	274
2019-07-01 to 2019-09-30	-1,084,544	USD	92
2019-01-01 to 2019-09-30	-2,712,584	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	737,123	USD	92
2020-01-01 to 2020-09-30	2,303,537	USD	274
2019-07-01 to 2019-09-30	601,567	USD	92
2019-01-01 to 2019-09-30	1,511,334	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	12,102	USD	274
2019-01-01 to 2019-09-30	1,430	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	194,863	USD	92
2020-01-01 to 2020-09-30	-298,115	USD	274
2019-07-01 to 2019-09-30	-319,455	USD	92
2019-01-01 to 2019-09-30	-894,425	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	2,905	USD	274
2019-01-01 to 2019-09-30	0	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	0	USD	274
2019-01-01 to 2019-09-30	0	USD	273

Inspect the source

Entity: NEUROPATHIX, INC. / CIK 0001615999
Captured: 2026-09-22 19:53 UTC
SEC response SHA-256: a975fe997e9854c9c4b078afe8f374baf90509e583bb6ae365c0229bf1a5418f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001615999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))